BVTI sure looks tempting, especially after the latest pullback. I see the company hopes to forge a collaboration in Europe.
Do you have any idea about the current FDA status for BiovaxID? Looks like the phase III trials were completed some time ago. Did the FDA request more information or is the company awaiting a final decision on the data they've already submitted?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.